- Home
- SLGL vs PXLW Comparison
SLGL vs PXLW Comparison
Compare SLGL & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- PXLW
- Stock Information
- Founded
- SLGL 1997
- PXLW 1997
- Country
- SLGL Israel
- PXLW United States
- Employees
- SLGL N/A
- PXLW N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- PXLW Semiconductors
- Sector
- SLGL Health Care
- PXLW Technology
- Exchange
- SLGL Nasdaq
- PXLW Nasdaq
- Market Cap
- SLGL 49.4M
- PXLW 50.2M
- IPO Year
- SLGL 2018
- PXLW 2000
- Fundamental
- Price
- SLGL $23.48
- PXLW $7.95
- Analyst Decision
- SLGL Buy
- PXLW Strong Buy
- Analyst Count
- SLGL 1
- PXLW 3
- Target Price
- SLGL $40.00
- PXLW $13.67
- AVG Volume (30 Days)
- SLGL 30.1K
- PXLW 60.8K
- Earning Date
- SLGL 08-15-2025
- PXLW 08-12-2025
- Dividend Yield
- SLGL N/A
- PXLW N/A
- EPS Growth
- SLGL N/A
- PXLW N/A
- EPS
- SLGL N/A
- PXLW N/A
- Revenue
- SLGL $23,931,000.00
- PXLW $33,961,000.00
- Revenue This Year
- SLGL N/A
- PXLW $5.21
- Revenue Next Year
- SLGL $31.17
- PXLW $35.68
- P/E Ratio
- SLGL N/A
- PXLW N/A
- Revenue Growth
- SLGL 264.86
- PXLW N/A
- 52 Week Low
- SLGL $4.01
- PXLW $4.67
- 52 Week High
- SLGL $26.89
- PXLW $15.03
- Technical
- Relative Strength Index (RSI)
- SLGL 72.14
- PXLW 41.63
- Support Level
- SLGL $20.06
- PXLW $7.75
- Resistance Level
- SLGL $26.89
- PXLW $8.80
- Average True Range (ATR)
- SLGL 2.57
- PXLW 0.93
- MACD
- SLGL 0.63
- PXLW -0.25
- Stochastic Oscillator
- SLGL 75.10
- PXLW 7.02
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.